focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,894.00
Bid: 1,886.00
Ask: 1,892.00
Change: 34.00 (1.83%)
Spread: 6.00 (0.318%)
Open: 1,828.00
High: 1,902.00
Low: 1,828.00
Prev. Close: 1,860.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Award for Incoming CEO

2 May 2023 07:00

RNS Number : 9825X
Genus PLC
02 May 2023
 

For Immediate Release 2 May 2023

Genus plc('Genus', or the 'Company')

Share Award for Incoming CEO

Further details on appointment of Chief Executive Officer

Disclosed below are the agreed reward arrangements for Jorgen Kokke, which are consistent with our shareholder approved Remuneration Policy.

 

He will be paid a basic annual salary of US$825,000. He will additionally receive a pension contribution worth 6% of this salary.

 

Jorgen will also receive payments following appointment of c£4m, the majority of which will be made in Genus share awards with future vesting dates subject to continued employment and which are set out below. These awards, which will be granted over Genus shares, are for loss of compensation of incentives held at Ingredion, the valuation of which has been determined in line with our Remuneration Policy, and which will be fully disclosed in our Annual Report. 

 

His ongoing variable reward opportunity will be structured as follows:

· An annual bonus opportunity of up to 200% of salary, with compulsory deferment of one-third of any bonus paid into shares, to be held for a minimum period of 3 years.

· In September 2023 (only) we will use the exceptional limit available within our Remuneration Policy to make a long term incentive award of 400% of salary under the Performance Share Plan (PSP). These awards will vest after three years subject to achievement against company performance targets, and will be subject to a further two year holding period following vesting. 

· In future years, expected to be from September 2024 onwards, long term awards will be in line with the standard level permissible our Remuneration Policy (currently 200% of salary). 

 

In addition to the above changes the Company provides the following updates:

· Further to the announcement of the forthcoming retirement of Stephen Wilson on 30 September, the Remuneration Committee has determined that Stephen will be treated as a good leaver from the business. The approach to reward will be in line with our agreed Remuneration Policy and we will make full disclosures as required under Section 430(2b) at the point of leaving and within our next Annual Report.

· Following determination of her future role and responsibilities and a market review of compensation, the Committee have decided to increase the salary for Alison Henriksen to £480,930 effective 1 July 2023. No further increases will be made in September 2023 or September 2024 with next scheduled review in September 2025. In reaching this decision the Board have considered and redefined the scope of the role that will be performed by Alison following the appointment of Jorgen Kokke. In particular, this will reflect the fact that she will be the sole Executive Director based primarily in the UK following the change of CEO. The Committee view this aspect as an extension of her current role, and this is reflected within the revised salary level that will be payable.

 

This announcement is made in accordance with Listing Rule 9.6.11R.

 

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 2 May 2023, Jorgen Kokke was granted awards of shares in respect of buyout of compensation forfeited from Ingredion as a result of his resignation. These have been awarded in line with the Company's Remuneration Policy, which is set out in our latest Annual Report.

 

These awards have been granted pursuant to Listing Rule 9.4.2R as nil-cost share options over ordinary shares on substantially similar terms to the Genus 2019 Performance Share Plan ('PSP'), but without further Genus company performance conditions and have been determined to be a fair value for awards that have been forfeited at Ingredion, with vesting dates designed to mirror the operation of those awards where applicable. Further details of the approach adopted by the Committee to determination of this value will be provided in our Annual Report. 

 

Date of Grant

Number of Nil-Cost Options Granted

Scheduled Vesting Date

2 May 2023

59,055

23 February 2024

2 May 2023

7,649

2 May 2024

2 May 2023

44,933

28 February 2025

2 May 2023

7,649

2 May 2025

2 May 2023

7,649

4 May 2026

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made on 2 May 2023.

 

For further information please contact:

 

 

Genus:

Dan Hartley, Group General Counsel and Company Secretary Tel: +44 (0)1256 347100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table A - Buy-out of Ingredion awards vesting on 23 February 2024

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

59,055

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table B - Buy-out of Ingredion awards vesting on 2 May 2024

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table C - Buy-out of Ingredion awards vesting on 28 February 2025

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

44,933

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table D - Buy-out of Ingredion awards vesting on 2 May 2025

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table E - Buy-out of Ingredion awards vesting on 4 May 2026

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSMFAFEDSEFI
Date   Source Headline
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.